期刊文献+

bFGF壳聚糖微球的制备及检测 被引量:4

PREPARATION OF BASIC FIBROBLAST GROWTH FACTOR CHITOSAN MICROSPHERE AND ITS PROPERTIES
原文传递
导出
摘要 目的探讨以壳聚糖为载体、采用乳化交联法制备的bFGF壳聚糖微球体外释放特性,为下一步实验奠定基础。方法应用0.6%三聚磷酸钠溶液作为交联剂,1.5%壳聚糖溶液作为载体,采用乳化交联法制备bFGF壳聚糖微球。激光粒度及Zeta电位分析仪检测微球粒径分布,扫描电镜观察形态;ELISA法计算bFGF壳聚糖微球载药量、包封率及体外释药规律。结果 bFGF壳聚糖微球粒径为20.312~24.152μm;扫描电镜观察显示微球表面光滑圆整,无明显孔隙,分布均匀,分散性好。载药量和包封率分别为(7.57±0.34)mg/g及95.14%±1.58%。bFGF壳聚糖微球可持续体外释放bFGF 24 d;bFGF浓度随时间延长逐渐升高,第24天达(820.45±21.34)ng/mL;微球体外释药具有突释效应,突释率为18.08%,24 d累计释放率为82.05%。结论乳化交联法制备bFGF壳聚糖微球操作简便,微球表面光滑、分布均匀,分散性好,载药量和包封率均较高,体外释药较稳定且释放率较高,是一种较理想的制备bFGF壳聚糖微球的方法。 Objective To study the release properties of basic fibroblast growth factor (bFGF) chitosan microspheres prepared by cross-linking-emulsion method using chitosan as a carrier material so as to lay a foundation for further study. Methods Using 0.6% sodium tripolyphosphate solution as a crosslinking agent and 1.5% solution of chitosan as a carrier material, bFGF chitosan microspheres were prepared by cross-linking-emulsion method. Laser particle size analyzer and Zeta electric potential analyzer were used to measure the particle diameter distribution, scanning electronic microscope to observe the morphology, and ELISA to determine the drug loading, the encapsulation rate, and the drug release properties. Results The particle size ofbFGF chitosan microspheres ranged 20.312-24.152 μm. The microspheres were round with a smooth surface and uniform distribution, and it had no apparent porosity. The drug loading and encapsulation rate of microspheres were (7.57 ±0.34) mg/g and 95.14% ±1.58%, respectively. The bFGF chitosan microspheres could continuously release bFGF for 24 days; the bFGF level increased gradually with time and reached (820.45± 21.34) ng/mL at 24 days; and the microspheres had a burst effect, and the burst rate was 18.08%, and the accumulative release rate of the microspheres reached 82.05% during 24 days. Conclusion It is easy-to-operate to prepare the bFGF chitosan microspheres with the cross-linking- emulsion method. The bFGF chitosan microspheres have smooth surface, uniform distribution, and no apparent porosity.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2012年第8期989-992,共4页 Chinese Journal of Reparative and Reconstructive Surgery
基金 四川省科技厅课题资助项目(05SG022-037)~~
关键词 BFGF 壳聚糖微球 乳化交联法 壳聚糖 Basic fibroblast growth factor Chitosan microsphere Cross-linking-emulsionmethod Chitosan
  • 相关文献

参考文献22

  • 1Okada-Ban M, Thiery JP, Iouanneau J. Fibroblast growth factor-2. Int J Biochem Cell Biol, 2000, 32(3): 263-267. 被引量:1
  • 2Jeon O, Kang S W, Lim HW. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly (1-1actide-co- glycolide) nanospheres and fibringel. Biomaterials, 2005, 8: 30-32. 被引量:1
  • 3张纲,谭颖徽,卢来春,张蓉,王建华,杜俊兰.bFGF-PLA缓释纳米微球的制备及体外释药的研究[J].重庆医学,2006,35(11):1002-1004. 被引量:10
  • 4黄鑫,孟国林,刘建,李丹,袁志,张金康,白建萍.rh-BMP-2壳聚糖微球的制备及体外检测[J].中国矫形外科杂志,2009,17(15):1172-1174. 被引量:15
  • 5李可欣,陈大为,赵秀丽,王丹蕾,郑畅.分散-交联法制备氟尿嘧啶壳聚糖微球的研究[J].中国药学杂志,2005,40(18):1392-1395. 被引量:7
  • 6Subramanian A, Lin HY, Vu D, et al. Synthesis and evaluation of scaf- folds prepared from chitosan fibers for potential use in cartilage tissue engineering. Biomed Sci Instrum, 2004, 40:117-122. 被引量:1
  • 7Wang AH, Chen XG, Liu CS, et al. Preparation and characteristics of chitosan microspheres in different acetylation as drug carrier system. 1 Microencapsul, 2008, 26(7): 593-602. 被引量:1
  • 8Zhang Y, Cheng X, Whng J, et al. Novel chitosan/collagen scaffold con- taining transforming growth factor-beta 1 DNA for periodontal tissue engineering. Biochem Biophys Res Commun, 2006, 344(1): 362-369. 被引量:1
  • 9Wang QZ, Chen XG, Li ZX, et al. Preparation and blood coagulation evaluation of chitosan microspheres. J Mater Sci Mater Med, 2008, 19 (3): 1371-1377. 被引量:1
  • 10Grenha A, Remucan-Lypez C, Carvalho EL, et al. Microspheres con- taining li pid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. Eur I Pharm Biopharm, 2008, 69(1): 83-93. 被引量:1

二级参考文献87

共引文献92

同被引文献49

  • 1常新,侯志明,柴田恭明,塚崎智雄,山口朗.碱性磷酸酶和骨钙素在成骨过程中表达的定量研究[J].华西口腔医学杂志,2005,23(5):424-426. 被引量:26
  • 2王宏辉.Preparation, Fundamental Characteristics and Biosafety Evalution of Compound rhBMP-2/CPC[J].Journal of Wuhan University of Technology(Materials Science),2006,21(2):116-119. 被引量:1
  • 3王增寿,胡伟,张华,朱光辉,陈怡.多柔比星壳聚糖微球的制备及其特性研究[J].医药导报,2007,26(7):720-723. 被引量:10
  • 4Cheung HK, Han TT, Marecak DM, et al. Composite hydrogelscaffolds incorporating deceilularized adipose tissue for soft tissueengineering with adipose-derived stem cells. Biomaterials, 2014,35(6): 1914-1923. 被引量:1
  • 5Nash GM, Bleier J, Milsom JW, et al. Minimally invasive surgery issafe and effective for urgent and emergent colectomy. Colorectal Dis,2010,12(5): 480-484. 被引量:1
  • 6Koshy ST, Ferrante TC, Lewin SA, et al. Injectable, porous, and cell-responsive gelatin cryogels. Biomaterials, 2014,35(8): 2477-2487. 被引量:1
  • 7Yang YP,Chien Y, Chiou GY, et al Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastomausing microRNAl45 with cationic polyurethane-short branch PEI.Biomaterials, 2012, 33(5): 1462-1476. 被引量:1
  • 8Nelson CH, Gupta MK, Adolph EJ, et al Sustained local delivery ofsiRNA from an injectable scaffold. Biomaterials> 2012, 33(4): 1154-1161. 被引量:1
  • 9Zhou L, Liang D, He X, et al. The degradation and biocompatibiJityof pH-sensitive biodegradable polyurethanes for intracellularmultifunctional anti tumor drug delivery. Biomaterials, 2012, 33(9):2734-2745. 被引量:1
  • 10Hu J, Chen B, Guo F, et al. Injectable silk fibroin/polyurethanecomposite hydrogel for nucleus pulposus replacement. / Mater SciMater Med, 2012,23(3): 711-722. 被引量:1

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部